BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2824015)

  • 1. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis.
    Klein WA; Miller HH; Anderson M; DeCosse JJ
    Cancer; 1987 Dec; 60(12):2863-8. PubMed ID: 2824015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis.
    Tsukada K; Church JM; Jagelman DG; Fazio VW; McGannon E; George CR; Schroeder T; Lavery I; Oakley J
    Dis Colon Rectum; 1992 Jan; 35(1):29-33. PubMed ID: 1310270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
    Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G
    Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors.
    Waddell WR; Kirsch WM
    Am J Surg; 1991 Apr; 161(4):416-21. PubMed ID: 2035759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac.
    Belliveau P; Graham AM
    Dis Colon Rectum; 1984 Jan; 27(1):53-4. PubMed ID: 6690265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis.
    Tsukada K; Church JM; Jagelman DG; Fazio VW; Lavery IC
    Dis Colon Rectum; 1991 Dec; 34(12):1090-2. PubMed ID: 1659977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment.
    Lotfi AM; Dozois RR; Gordon H; Hruska LS; Weiland LH; Carryer PW; Hurt RD
    Int J Colorectal Dis; 1989; 4(1):30-6. PubMed ID: 2540254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
    Hansmann A; Adolph C; Vogel T; Unger A; Moeslein G
    Cancer; 2004 Feb; 100(3):612-20. PubMed ID: 14745880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac for polyposis of the colon.
    Waddell WR; Ganser GF; Cerise EJ; Loughry RW
    Am J Surg; 1989 Jan; 157(1):175-9. PubMed ID: 2535920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoid disease in patients with familial adenomatous polyposis.
    Soravia C; Berk T; McLeod RS; Cohen Z
    Dis Colon Rectum; 2000 Mar; 43(3):363-9. PubMed ID: 10733118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac plus erlotinib for familial adenomatous polyposis.
    Baker H
    Lancet Oncol; 2016 May; 17(5):e183. PubMed ID: 27051970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complete remission of a mesenteric fibromatosis after taking sulindac].
    D'Alteroche L; Benchellal ZA; Salem N; Regimbeau C; Picon L; Metman EH
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1098-101. PubMed ID: 10051987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desmoid tumors or intra-abdominal fibromatoses].
    Lasser P; Elias D; Contesso G; Genin J; Mankarios H; Rougier P
    Ann Chir; 1993; 47(4):352-9. PubMed ID: 8352514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel obstruction in patients with familial adenomatous polyposis related desmoid disease.
    Xhaja X; Church J
    Colorectal Dis; 2013 Dec; 15(12):1489-92. PubMed ID: 24020802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
    Kadmon M; Möslein G; Buhr HJ; Herfarth C
    Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac for polyposis of the colon.
    Waddell WR; Loughry RW
    J Surg Oncol; 1983 Sep; 24(1):83-7. PubMed ID: 6887943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of nonsteroidal anti-inflammatory drugs (NSAID) on colorectal polyps in patients with familial adenomatous polyposis: a review of clinical studies].
    Akasu T; Kakizoe T
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):385-90. PubMed ID: 9695077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of an aggressive abdominal desmoid tumor in a patient with familial adenomatous polyposis by hyperthermoradiotherapy.
    Oohata Y; Mibu R; Uehara S; Iida M; Ishikawa M; Sakai M; Tanaka M
    Am J Gastroenterol; 1997 Jan; 92(1):156-8. PubMed ID: 8995959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.